Replies to post #17 on Arcturus Therapeutics (ARCT)

[Willymon]

$ARCT - Singapore has set and is setting the example to follow in all this.

The fact that they selected $ARCT to develop a cure is very telling.

Arcturus announced that it is partnering with Duke-NUS, a partnership between the Duke University School of Medicine and the National University of Singapore, to develop a COVID-19 vaccine to prevent infection by the coronavirus. The government of Singapore will pay for the vaccine's development -- $10 million to be paid part up-front, part upon achievement of unspecified "development milestones." And Singapore will get first dibs on any vaccines produced (plus potential royalties on vaccine sales outside of Singapore).Link>